Leading source of Financial News, Investor Forums, CEO Interviews, Financial Columnists, Stock Information

Add to MyProactive

Kazia Therapeutics Ltd - Kazia Therapeutics to join international study in glioblastoma with lead program GDC-0084

Kazia Therapeutics to join international study in glioblastoma with lead program GDC-0084

4 hours, 38 minutes ago

Admedus Ltd - Admedus sells 12,500 units of CardioCel® and VascuCel® patches to Le Maitre Vascular Inc

Admedus sells 12,500 units of CardioCel® and VascuCel® patches to Le Maitre Vascular Inc

2 days, 1 hour ago

Opyl Ltd - Opyl to use artificial intelligence to transform Australia’s healthcare sector

Opyl to use artificial intelligence to digitally transform Australia’s healthcare sector

2 days, 2 hours ago

Cellmid Limited - Cellmid's latest sale event brings in $1.13 million on Japanese shopping channel QVC

Cellmid's sale event brings in $1.13 million on Japanese TV shopping channel

5 days, 9 hours ago

Imugene Ltd - Imugene appoints surgeon-scientist Dr Rebecca Auer to oncolytic virotherapy advisory board

Imugene appoints surgeon-scientist Dr Rebecca Auer to oncolytic virotherapy advisory board

6 days, 6 hours ago

THC Global Group Ltd - THC Global processes first farm-to-pharma medicinal cannabis at Southport Facility

THC Global processes first farm-to-pharma medicinal cannabis at Southport Facility

1 week ago

Imugene Ltd - Imugene’s immunotherapy strategy given stamp of approval through oversubscribed placement

Imugene’s immunotherapy strategy given stamp of approval in oversubscribed placement

1 week, 2 days ago

Imugene Ltd - Imugene director increases stake, capital raising underway

Imugene director increases stake, capital raising underway

1 week, 5 days ago

Imugene Ltd - Imugene in trading halt with capital raising pending

Imugene in trading halt with capital raising news pending

1 week, 6 days ago

ShareRoot Ltd - ShareRoot’s shareholders provide seal of approval for name change to Opyl

Tech

ShareRoot’s shareholders provide seal of approval for name change to Opyl

2 weeks ago

Kazia Therapeutics Ltd - Kazia Therapeutics shares surge after positive early results for GDC-0084 in brain cancer patients

Kazia Therapeutics shares surge after positive early phase II study results for GDC-0084 in brain cancer patients

2 weeks, 2 days ago

Kazia Therapeutics Ltd - Kazia Therapeutics releases data from study of GDC-0084 into aggressive form of brain cancer

Full interview: Kazia Therapeutics releases data from study of GDC-0084 into aggressive form of brain cancer

2 weeks, 2 days ago

Imugene Ltd - Imugene plans two separate phase I clinical trials for CF33 oncolytic virus

Imugene plans two separate phase I clinical trials for CF33 oncolytic virus

2 weeks, 2 days ago

Cellmid Limited - Cellmid Ltd’s board of directors show faith in the company by participating in share placement

Cellmid directors show faith in company by participating in share placement

2 weeks, 5 days ago

Cellmid Limited -

Cellmid makes key retail collaborations and continues to kick strategic goals

2 weeks, 6 days ago

Admedus Ltd - Admedus receives price and volume query after shares surge

Admedus receives price and volume query after shares surge

3 weeks ago

Imugene Ltd - Imugene appoints distinguished physician and scientist to the Scientific Advisory Board

Imugene appoints distinguished physician and scientist to the Scientific Advisory Board

3 weeks ago

Paradigm Biopharmaceuticals Ltd - Paradigm Biopharmaceuticals’ board member buys $300,000 worth of shares

Paradigm Biopharmaceuticals’ board member buys $300,000 worth of shares

3 weeks ago

Admedus Ltd - Admedus Ltd proud to unveil its valves publicly for the first time in London

Admedus Ltd proud to unveil its valves publicly for the first time in London

3 weeks ago

chart showing data value appreciation

ShareRoot plans Opyl transformation under leadership of Michelle Gallaher and Julian Chick

3 weeks, 1 day ago